rs77580616

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031220.4(PITPNM3):​c.901-10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,613,364 control chromosomes in the GnomAD database, including 781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 75 hom., cov: 32)
Exomes 𝑓: 0.013 ( 706 hom. )

Consequence

PITPNM3
NM_031220.4 intron

Scores

2
Splicing: ADA: 0.000008068
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.09

Publications

3 publications found
Variant links:
Genes affected
PITPNM3 (HGNC:21043): (PITPNM family member 3) This gene encodes a member of a family of membrane-associated phosphatidylinositol transfer domain-containing proteins. The calcium-binding protein has phosphatidylinositol (PI) transfer activity and interacts with the protein tyrosine kinase PTK2B (also known as PYK2). The protein is homologous to a Drosophila protein that is implicated in the visual transduction pathway in flies. Mutations in this gene result in autosomal dominant cone dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
PITPNM3 Gene-Disease associations (from GenCC):
  • cone-rod dystrophy 5
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-6477223-C-G is Benign according to our data. Variant chr17-6477223-C-G is described in ClinVar as Benign. ClinVar VariationId is 96202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PITPNM3NM_031220.4 linkc.901-10G>C intron_variant Intron 8 of 19 ENST00000262483.13 NP_112497.2 Q9BZ71-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PITPNM3ENST00000262483.13 linkc.901-10G>C intron_variant Intron 8 of 19 1 NM_031220.4 ENSP00000262483.8 Q9BZ71-1
PITPNM3ENST00000572795.1 linkn.3407-10G>C intron_variant Intron 2 of 13 1
PITPNM3ENST00000421306.7 linkc.793-10G>C intron_variant Intron 7 of 18 2 ENSP00000407882.3 Q9BZ71-3

Frequencies

GnomAD3 genomes
AF:
0.0119
AC:
1808
AN:
152064
Hom.:
75
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.0417
Gnomad FIN
AF:
0.0142
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00685
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0214
AC:
5379
AN:
250910
AF XY:
0.0221
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00283
Gnomad ASJ exome
AF:
0.00755
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.0155
Gnomad NFE exome
AF:
0.00699
Gnomad OTH exome
AF:
0.0119
GnomAD4 exome
AF:
0.0126
AC:
18348
AN:
1461182
Hom.:
706
Cov.:
31
AF XY:
0.0132
AC XY:
9617
AN XY:
726950
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33468
American (AMR)
AF:
0.00300
AC:
134
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00930
AC:
243
AN:
26132
East Asian (EAS)
AF:
0.163
AC:
6458
AN:
39690
South Asian (SAS)
AF:
0.0354
AC:
3051
AN:
86228
European-Finnish (FIN)
AF:
0.0157
AC:
833
AN:
53216
Middle Eastern (MID)
AF:
0.00693
AC:
40
AN:
5768
European-Non Finnish (NFE)
AF:
0.00598
AC:
6649
AN:
1111584
Other (OTH)
AF:
0.0146
AC:
881
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
966
1932
2897
3863
4829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0119
AC:
1810
AN:
152182
Hom.:
75
Cov.:
32
AF XY:
0.0135
AC XY:
1004
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41512
American (AMR)
AF:
0.00347
AC:
53
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3470
East Asian (EAS)
AF:
0.158
AC:
814
AN:
5164
South Asian (SAS)
AF:
0.0418
AC:
201
AN:
4812
European-Finnish (FIN)
AF:
0.0142
AC:
151
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00685
AC:
466
AN:
68002
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
88
176
265
353
441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00909
Hom.:
4
Bravo
AF:
0.0105
Asia WGS
AF:
0.0720
AC:
250
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 30, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone-rod dystrophy 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
11
DANN
Benign
0.73
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000081
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77580616; hg19: chr17-6380543; COSMIC: COSV52593841; COSMIC: COSV52593841; API